Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01043250
What this trial is testing

Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

Who this might be right for
SchizophreniaSchizoaffective Disorder
Samsung Medical Center 81
Not applicableStudy completedNCT01338298
What this trial is testing

Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia

Who this might be right for
Hyperprolactinemia
University of Maryland, Baltimore 60
Post-approval studies (Phase 4)Study completedNCT03289026
What this trial is testing

Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study

Who this might be right for
Acute Schizophrenia Episode
Peking University 770
Large-scale testing (Phase 3)Study completedNCT00221416
What this trial is testing

An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder

Who this might be right for
Bipolar Disorder
University of Cincinnati 30
Large-scale testing (Phase 3)Ended earlyNCT01111565
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 137
Not applicableStudy completedNCT00573716
What this trial is testing

Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents

Who this might be right for
Psychiatry
Creighton University 60
Not applicableStudy completedNCT00312598
What this trial is testing

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
University of North Carolina, Chapel Hill 30
Large-scale testing (Phase 3)Study completedNCT00731549
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,081
Post-approval studies (Phase 4)UnknownNCT06501339
What this trial is testing

Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole in Clozapine-resistant Schizophrenia

Who this might be right for
Clozapine Resistant Schizophrenia
All India Institute of Medical Sciences, Bhubaneswar 40
Not applicableEnded earlyNCT00211302
What this trial is testing

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)

Who this might be right for
SchizophreniaSchizoaffective Disorder
Louisiana State University Health Sciences Center Shreveport 8
Not applicableUnknownNCT01075373
What this trial is testing

A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations

Who this might be right for
Schizophrenia
National Taiwan University Hospital 360
Post-approval studies (Phase 4)Ended earlyNCT00592683
What this trial is testing

Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents

Who this might be right for
Pediatric Bipolar Disorder
Massachusetts General Hospital 20
Post-approval studies (Phase 4)Study completedNCT00438386
What this trial is testing

Aripiprazole for the Treatment of Refractory Anxiety

Who this might be right for
Generalized Anxiety DisorderPanic Disorder
Massachusetts General Hospital
Post-approval studies (Phase 4)Study completedNCT00305370
What this trial is testing

Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD

Who this might be right for
Bipolar DisorderAttention Deficit Hyperactivity Disorder
Federal University of Rio Grande do Sul 20
Large-scale testing (Phase 3)Study completedNCT01710709
What this trial is testing

Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder

Who this might be right for
Bipolar I
Otsuka Pharmaceutical Development & Commercialization, Inc. 748
Large-scale testing (Phase 3)Study completedNCT00237939
What this trial is testing

Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,200
Post-approval studies (Phase 4)Study completedNCT01429831
What this trial is testing

Aripiprazole for the Augmentation of Antidepressant Therapy

Who this might be right for
Major Depressive Disorder
Taiwan Otsuka Pharm. Co., Ltd 300
Not applicableStudy completedNCT00953745
What this trial is testing

Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Washington University School of Medicine 43
Post-approval studies (Phase 4)WithdrawnNCT02213887
What this trial is testing

Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications

Who this might be right for
Psychotic DisordersGastroesophageal Reflux
University of British Columbia
Large-scale testing (Phase 3)Study completedNCT01655706
What this trial is testing

Canadian Biomarker Integration Network for Depression Study

Who this might be right for
Major Depressive Disorder
University Health Network, Toronto 211
Next Page